Approval · Notice of Compliance 27642 · 2022
BRUKINSA: Notice of Compliance 27642
Issued February 18, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27642
- Date
- February 18, 2022
- Company
- Beigene Switzerland Gmbh
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- To obtain market authorization for a new indication.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRUKINSA | Not yet assigned | — |
Medicinal ingredients
- ZANUBRUTINIB 80 MG per CAP